SETDB1 anticorps

N° du produit ABIN7118993

Détail du produit anti-SETDB1 anticorps

Antigène: SETDB1 (SET Domain, Bifurcated 1 (SETDB1))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SETDB1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Purification: Immunogen affinity purified

Pureté: ≥95 % as determined by SDS-PAGE

Immunogène: SET domain, bifurcated 1

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500 - 1:2000, IHC: 1:50 - 1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3 ,

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Date de péremption: 12 months

Détails sur SETDB1

Antigène: SETDB1 (SET Domain, Bifurcated 1 (SETDB1))

Autre désignation: SETDB1 (SETDB1 Produits)

Synonymes: anticorps ESET, anticorps H3-K9-HMTase4, anticorps KG1T, anticorps KMT1E, anticorps TDRD21, anticorps AU022152, anticorps mKIAA0067, anticorps SETDB1, anticorps NV10069, anticorps fc07d03, anticorps si:ch211-81a5.6, anticorps wu:fc07d03, anticorps im:7143091, anticorps wu:fa04a12, anticorps wu:fj80h02, anticorps zgc:152899, anticorps SET domain bifurcated 1, anticorps SET domain, bifurcated 1, anticorps myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11, anticorps histone-lysine N-methyltransferase SETDB1, anticorps SET domain, bifurcated 1a, anticorps SET domain bifurcated 1 L homeolog, anticorps SET domain, bifurcated 1b, anticorps SETDB1, anticorps Setdb1, anticorps MLLT11, anticorps LOC100120014, anticorps LOC100461671, anticorps setdb1a, anticorps setdb1.L, anticorps setdb1b

Sujet: Synonyms:KIAA0067, KMT1E Background:This gene encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. This gene has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. Alternatively spliced transcript variants of this gene have been described.

Poids moléculaire: 210 kDa

ID gène: 9869

UniProt: Q15047